Mohsen Moohebati Selected Research

HSP27 Heat-Shock Proteins

1/2019	The Effects of Curcumin on Serum Heat Shock Protein 27 Antibody Titers in Patients with Metabolic Syndrome.
8/2017	Relationship between serum anti-heat shock protein 27 antibody levels and obesity.
1/2013	Changes in anti-heat shock protein 27 antibody and C-reactive protein levels following cardiac surgery and their association with cardiac function in patients with cardiovascular disease.
11/2012	Anti-heat shock protein 27 titers and oxidative stress levels are elevated in patients with valvular heart disease.
1/2012	Changes in plasma level of heat shock protein 27 after acute coronary syndrome.
12/2011	A cross-sectional study of the association between heat shock protein 27 antibody titers, pro-oxidant-antioxidant balance and metabolic syndrome in patients with angiographically-defined coronary artery disease.
5/2011	Serum antibody titers against heat shock protein 27 are associated with the severity of coronary artery disease.
6/2008	Antibody titres to heat shock protein 27 are elevated in patients with acute coronary syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohsen Moohebati Research Topics

Disease

32	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2007
15	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 06/2011
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 02/2011
8	Inflammation (Inflammations) 01/2021 - 01/2007
7	Atherosclerosis 01/2021 - 04/2009
7	Obesity 10/2020 - 01/2011
6	Coronary Disease (Coronary Heart Disease) 01/2019 - 01/2007
5	Diabetes Mellitus 03/2020 - 06/2011
5	Pathologic Constriction (Stenosis) 01/2019 - 10/2012
4	Stroke (Strokes) 01/2022 - 01/2018
4	Acute Coronary Syndrome 11/2016 - 06/2008
3	Hypertension (High Blood Pressure) 07/2022 - 11/2019
3	Coronary Stenosis (Coronary Artery Stenosis) 01/2021 - 10/2012
3	Dyslipidemias (Dyslipidemia) 03/2020 - 01/2018
3	Insulin Resistance 09/2012 - 01/2007
2	Essential Hypertension 01/2021 - 11/2018
2	Neoplasms (Cancer) 08/2017 - 09/2016
2	Heart Valve Diseases (Valvular Heart Disease) 01/2015 - 11/2012
1	Ventricular Remodeling 02/2021
1	Heart Failure 02/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Vascular Diseases (Vascular Disease) 01/2021
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2021
1	Abdominal Obesity 10/2020
1	Hypertriglyceridemia 10/2020
1	Anxiety Disorders (Anxiety Disorder) 07/2017
1	Myocardial Ischemia (Ischemic Heart Diseases) 11/2016
1	ST Elevation Myocardial Infarction 06/2015
1	Cardiac Arrhythmias (Arrythmia) 06/2015

Drug/Important Bio-Agent (IBA)

14	C-Reactive ProteinIBA 02/2021 - 01/2007
13	AntioxidantsIBA 01/2021 - 04/2008
9	oxidized low density lipoproteinIBA 01/2022 - 01/2012
9	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 12/2009
8	HSP27 Heat-Shock ProteinsIBA 01/2019 - 06/2008
6	Triglycerides (Triacylglycerol)IBA 03/2020 - 01/2007
6	Biomarkers (Surrogate Marker)IBA 05/2019 - 01/2007
4	LDL CholesterolIBA 01/2022 - 10/2018
4	CholesterolIBA 03/2020 - 09/2012
4	Neuropeptide YIBA 03/2015 - 03/2012
4	Immunoglobulin G (IgG)IBA 01/2015 - 06/2008
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2011
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2019 - 05/2011
3	AntibodiesIBA 01/2019 - 02/2011
3	Uric Acid (Urate)IBA 11/2018 - 01/2018
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2014 - 01/2012
2	Therapeutic UsesIBA 07/2022 - 02/2021
2	Antihypertensive Agents (Antihypertensives)IBA 07/2022 - 03/2020
2	Pharmaceutical PreparationsIBA 07/2022 - 03/2020
2	CytokinesIBA 01/2021 - 11/2017
2	CalciumIBA 06/2020 - 09/2018
2	HDL CholesterolIBA 03/2020 - 03/2019
2	LipidsIBA 03/2020 - 09/2012
2	Blood Glucose (Blood Sugar)IBA 03/2019 - 09/2016
2	CurcuminIBA 01/2019 - 11/2017
2	Type 1 Angiotensin ReceptorIBA 11/2016 - 06/2011
2	Adenosine Triphosphate (ATP)IBA 07/2015 - 06/2011
2	Malondialdehyde (Propanedial)IBA 01/2015 - 01/2012
2	ZincIBA 01/2012 - 01/2007
2	CopperIBA 01/2012 - 01/2007
2	MetalsIBA 02/2011 - 02/2011
1	3-n-butylphthalide (butylphthalide)IBA 07/2022
1	Proline (L-Proline)FDA Link 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	pro-brain natriuretic peptide (1-76)IBA 02/2021
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 02/2021
1	FluoridesIBA 01/2021
1	Dietary ProteinsIBA 01/2021
1	Vitamin E FDA LinkGeneric 01/2021
1	Apolipoproteins B (ApoB)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	erucylphosphocholineIBA 01/2021
1	dimethylargininaseIBA 01/2021
1	Drinking WaterIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 10/2020
1	N-(4-aminophenethyl)spiroperidol (NAPS)IBA 10/2020
1	Phosphorus (Red Phosphorus)IBA 06/2020
1	IodineIBA 06/2020
1	Aryldialkylphosphatase (Paraoxonase)IBA 03/2019
1	HDL LipoproteinsIBA 02/2019
1	Small Heat-Shock ProteinsIBA 01/2019
1	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 01/2019
1	ORALIT (ORS)IBA 01/2019
1	CarbohydratesIBA 01/2019
1	Oxidants (Oxidizing Agents)IBA 01/2019
1	TransferasesIBA 11/2018
1	Phosphates (Orthophosphate)IBA 09/2018
1	25-hydroxyvitamin DIBA 09/2018
1	Arginine (L-Arginine)FDA Link 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 11/2017
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2017
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 09/2017
1	Cytokine Receptors (Cytokine Receptor)IBA 09/2017
1	AntigensIBA 08/2017
1	MB Form Creatine KinaseIBA 11/2016
1	Erythropoietin FDA Link 06/2015

Therapy/Procedure

3	Stents 01/2019 - 02/2011
2	Drug-Eluting Stents 02/2011 - 02/2011
1	Therapeutics 01/2021
1	Transplantation 01/2021